Patents by Inventor Suzanne J. Hodgkinson

Suzanne J. Hodgkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD4+ CD25+ T-CELLS ACTIVATED TO A SPECIFIC ANTIGEN
    Publication number: 20140370038
    Abstract: The invention relates to a method of assessing whether a subject includes CD4+,CD25+ T cells that have been activated to a specific antigen. The method includes the steps of obtaining from the subject a sample of lymphocytes including CD4+,CD25+ T cells, incubating at least one portion of the sample of lymphocytes so as to promote, distinction of CD4+,CD25+ T cells that have been activated to the specific antigen from those CD4+,CD25+ T cells that have not been activated to the specific antigen, and thereafter determining whether CD4+,CD25+ T cells activated to the specific antigen are present in the sample. The invention further relates to methods of growing CD4+, CD25+ T cells that have been activated to a specific antigen in vitro and to methods of increasing tolerance in a subject using the CD4+, CD25+ T cells that have been grown in vitro.
    Type: Application
    Filed: June 23, 2014
    Publication date: December 18, 2014
    Inventors: Bruce M. Hall, Suzanne J. Hodgkinson
  • Cd4+ Cd25+ T-cells activated to a specific antigen
    Patent number: 8785140
    Abstract: The invention relates to a method of assessing whether a subject comprises CD4+,CD25+ T cells that have been activated to a specific antigen. The method comprises the steps of obtaining from the subject a sample of lymphocytes comprising CD4+,CD25+ T cells, incubating at least one portion of the sample of lymphocytes so as to promote distinction of CD4+,CD25+ T cells that have been activated to the specific antigen from those CD4+,CD25+ T cells that have not been activated to the specific antigen, and thereafter determining whether CD4+,CD25+ T cells activated to the specific antigen are present in the sample. The invention further relates to methods of growing CD4+, CD25+ T cells that have been activated to a specific antigen in vitro and to methods of increasing tolerance in a subject using the CD4+, CD25+ T cells that have been grown in vitro.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: July 22, 2014
    Assignee: New South Innovations Pty Limited
    Inventors: Bruce M. Hall, Suzanne J. Hodgkinson
  • Method of identifying CD4CD25T-cells activated to an antigen which express CD8
    Patent number: 8569059
    Abstract: The invention relates to a method of identifying CD4+ CD25+ T cells activated to an antigen in a population of T cells, comprising identifying CD4+ CD25+ T cells which express CD8. The invention also relates to a method of isolating CD4+ CD25+ T cells activated to an antigen comprising isolating CD4+ CD25+ T cells which express CD8. The invention also relates to a method of increasing tolerance to an antigen in a subject comprising administering CD4+ CD25+ T cells which express CD8.
    Type: Grant
    Filed: August 2, 2007
    Date of Patent: October 29, 2013
    Assignee: Newsouth Innovations Pty Limited
    Inventors: Bruce Milne Hall, Suzanne J. Hodgkinson
  • METHOD OF IDENTIFYING CD4+ CD25+ T-CELLS ACTIVATED TO AN ANTIGEN WHICH EXPRESS CD8
    Publication number: 20110311559
    Abstract: The invention relates to a method of identifying CD4+ CD25+ T cells activated to an antigen in a population of T cells, comprising identifying CD4+ CD25+ T cells which express CD8. The invention also relates to a method of isolating CD4+ CD25+ T cells activated to an antigen comprising isolating CD4+ CD25+ T cells which express CD8. The invention also relates to a method of increasing tolerance to an antigen in a subject comprising administering CD4+ CD25+ T cells which express CD8.
    Type: Application
    Filed: August 2, 2007
    Publication date: December 22, 2011
    Inventors: Bruce Milne Hall, Suzanne J. Hodgkinson
  • Cd4+ Cd25+ T-Cells Activated to a Specific Antigen
    Publication number: 20080279813
    Abstract: The invention relates to a method of assessing whether a subject comprises CD4+,CD25+ T cells that have been activated to a specific antigen. The method comprises the steps of obtaining from the subject a sample of lymphocytes comprising CD4+,CD25+ T cells, incubating at least one portion of the sample of lymphocytes so as to promote distinction of CD4+,CD25+ T cells that have been activated to the specific antigen from those CD4+,CD25+ T cells that have not been activated to the specific antigen, and thereafter determining whether CD4+,CD25+ T cells activated to the specific antigen are present in the sample. The invention further relates to methods of growing CD4+, CD25+ T cells that have been activated to a specific antigen in vitro and to methods of increasing tolerance in a subject using the CD4+, CD25+ T cells that have been grown in vitro.
    Type: Application
    Filed: February 2, 2006
    Publication date: November 13, 2008
    Inventors: Bruce M. Hall, Suzanne J. Hodgkinson